These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 29606064)
1. Ketamine: Quo Vadis? Nemeroff CB Am J Psychiatry; 2018 Apr; 175(4):297-299. PubMed ID: 29606064 [No Abstract] [Full Text] [Related]
2. Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial. Ionescu DF; Bentley KH; Eikermann M; Taylor N; Akeju O; Swee MB; Pavone KJ; Petrie SR; Dording C; Mischoulon D; Alpert JE; Brown EN; Baer L; Nock MK; Fava M; Cusin C J Affect Disord; 2019 Jan; 243():516-524. PubMed ID: 30286416 [TBL] [Abstract][Full Text] [Related]
3. Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial. Murrough JW; Soleimani L; DeWilde KE; Collins KA; Lapidus KA; Iacoviello BM; Lener M; Kautz M; Kim J; Stern JB; Price RB; Perez AM; Brallier JW; Rodriguez GJ; Goodman WK; Iosifescu DV; Charney DS Psychol Med; 2015 Dec; 45(16):3571-80. PubMed ID: 26266877 [TBL] [Abstract][Full Text] [Related]
4. Ketamine rapidly relieves acute suicidal ideation in cancer patients: a randomized controlled clinical trial. Fan W; Yang H; Sun Y; Zhang J; Li G; Zheng Y; Liu Y Oncotarget; 2017 Jan; 8(2):2356-2360. PubMed ID: 27926528 [TBL] [Abstract][Full Text] [Related]
5. Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study. Ionescu DF; Swee MB; Pavone KJ; Taylor N; Akeju O; Baer L; Nyer M; Cassano P; Mischoulon D; Alpert JE; Brown EN; Nock MK; Fava M; Cusin C J Clin Psychiatry; 2016 Jun; 77(6):e719-25. PubMed ID: 27232360 [TBL] [Abstract][Full Text] [Related]
6. Ketamine versus midazolam in bipolar depression with suicidal thoughts: A pilot midazolam-controlled randomized clinical trial. Grunebaum MF; Ellis SP; Keilp JG; Moitra VK; Cooper TB; Marver JE; Burke AK; Milak MS; Sublette ME; Oquendo MA; Mann JJ Bipolar Disord; 2017 May; 19(3):176-183. PubMed ID: 28452409 [TBL] [Abstract][Full Text] [Related]
7. Ketamine for suicidal ideation treatment: Available evidence remains convincing. Bartoli F; Crocamo C; Carrà G Neurosci Biobehav Rev; 2019 Apr; 99():1-2. PubMed ID: 30682382 [No Abstract] [Full Text] [Related]
8. Reduction in Suicidal Ideation Following Repeated Doses of Intravenous Ketamine? Apeldoorn SY; de Boer MK; Schoevers RA J Clin Psychiatry; 2017 Jan; 78(1):e71. PubMed ID: 28129500 [No Abstract] [Full Text] [Related]
9. Opioid Receptor μ-1 and Ketamine Effects in a Suicidal Depression Trial: A Post Hoc Exploration. Grunebaum MF; Galfalvy HC; Liu J; Huang YY; Marcott S; Burke AK; Mann JJ J Clin Psychopharmacol; 2020; 40(4):420-422. PubMed ID: 32590406 [No Abstract] [Full Text] [Related]
10. Role of Ketamine in Severe Depression with suicidal ideation - Insights from a Case Study. Gurnani T; Khurshid KA Asian J Psychiatr; 2017 Oct; 29():112-113. PubMed ID: 29061405 [No Abstract] [Full Text] [Related]
11. Two cases of delayed-onset suicidal ideation, dysphoria and anxiety after ketamine infusion in patients with obsessive-compulsive disorder and a history of major depressive disorder. Niciu MJ; Grunschel BD; Corlett PR; Pittenger C; Bloch MH J Psychopharmacol; 2013 Jul; 27(7):651-4. PubMed ID: 23676198 [TBL] [Abstract][Full Text] [Related]
12. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action. Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038 [TBL] [Abstract][Full Text] [Related]
13. Urgent ketamine infusion rapidly eliminated suicidal ideation for a patient with major depressive disorder: a case report. Zigman D; Blier P J Clin Psychopharmacol; 2013 Apr; 33(2):270-2. PubMed ID: 23422387 [No Abstract] [Full Text] [Related]
14. Ketamine and esketamine for suicidal ideation: Recent progress and practical issues. Bartoli F; Wlkinson ST Aust N Z J Psychiatry; 2020 Feb; 54(2):206-207. PubMed ID: 31830803 [No Abstract] [Full Text] [Related]
15. Recurrent Suicidal Ideation During Intravenous Ketamine Treatment. Smith AWT; Virk S Am J Ther; 2019; 26(6):e732-e735. PubMed ID: 30946043 [No Abstract] [Full Text] [Related]
16. Nitrous Oxide Reduced Suicidal Ideation in Treatment-Resistant Major Depression in Exploratory Analysis. de Leon VC; Kumar A; Nagele P; Palanca BJ; Gott B; Janski A; Zorumski CF; Conway CR J Clin Psychiatry; 2023 Aug; 84(5):. PubMed ID: 37585253 [No Abstract] [Full Text] [Related]
17. Efficacy and Safety of a Rapid Intravenous Injection of Ketamine 0.5 mg/kg in Treatment-Resistant Major Depression: An Open 4-Week Longitudinal Study. Vidal S; Gex-Fabry M; Bancila V; Michalopoulos G; Warrot D; Jermann F; Dayer A; Sterpenich V; Schwartz S; Vutskits L; Khan N; Aubry JM; Kosel M J Clin Psychopharmacol; 2018 Dec; 38(6):590-597. PubMed ID: 30346333 [TBL] [Abstract][Full Text] [Related]
18. Ketamine and suicidal ideation in depression: Jumping the gun? Rajkumar R; Fam J; Yeo EY; Dawe GS Pharmacol Res; 2015 Sep; 99():23-35. PubMed ID: 25982932 [TBL] [Abstract][Full Text] [Related]
20. The use of esketamine in the treatment of patients with severe depression and suicidal ideation: systematic review and meta-analysis. Floriano I; Silvinato A; Bernardo WM Rev Assoc Med Bras (1992); 2023; 69(4):e2023D694. PubMed ID: 37194806 [No Abstract] [Full Text] [Related] [Next] [New Search]